MicroRNAs (miRNAs) are an abundant class of small non-coding RNAs that regulate diverse biological processes. Recent studies suggest that a cluster of miRNAs, the mir-17-92 polycistron located at 13q31, which contains seven miRNAs including miR-17-5p, miR-17-3p, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR- 92-1, may function as an oncogene. These miRNAs are highly expressed in many malignant lymphomas and other neoplasms that contain amplified 13q31-32 chromosomal fragments. It has been demonstrated that enforced expression of the mir-17-92 cluster cooperated with c-myc expression to accelerate tumor development in a mouse model of human B-cell lymphoma, and that introduction of the expression construct of the mir-17-92 cluster could enhance lung cancer cell growth. However, it is unclear whether enforced expression of this miRNA cluster can induce cancer alone or must cooperate with other gene abnormalities. Moreover, the functional mechanisms through which the miRNAs contribute to the development of cancer are poorly understood. Recently, we observed that the miRNAs from this cluster are frequently overexpressed in various acute leukemias, particularly in MLL-rearrangement leukemia, although the degree of up-regulation varies between individual miRNAs. The overexpression of these miRNAs is usually correlated with the amplification of the miRNA cluster at its genomic locus. Thus, we hypothesize that the miRNAs from the mir- 17-92 cluster play a role in hematopoiesis, and that overexpression of the miRNAs may contribute to the development of leukemia alone and/or by cooperating with other abnormalities, e.g., MLL translocations. We also hypothesize that some of the miRNAs in the cluster may play a greater role than others in leukemogenesis. In addition, we hypothesize that overexpression of the miRNAs contributes to leukemogenesis by negatively regulating expression of their target genes, particularly those that are critical tumor suppressors. We propose to explore the role of each of the miRNAs and of the different combinations of these miRNAs in proliferation and differentiation of hematopoietic progenitor cells, and in leukemogenesis by using two different mouse transplantation models. Finally, we have identified 21 highly likely target genes of the miRNAs from this cluster through our recent preliminary studies, and we will validate further the miRNA- target relationship and study the roles of the validated targets in the development of leukemia by using both in vitro and in vivo methods.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA127277-05
Application #
8242818
Study Section
Molecular Oncogenesis Study Section (MONC)
Program Officer
Howcroft, Thomas K
Project Start
2008-06-01
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2014-04-30
Support Year
5
Fiscal Year
2012
Total Cost
$278,061
Indirect Cost
$96,914
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Jiang, Xi; Hu, Chao; Arnovitz, Stephen et al. (2016) miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat Commun 7:11452
Li, Zejuan; Chen, Ping; Su, Rui et al. (2016) PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease. Cancer Res 76:619-29
Jiang, Xi; Bugno, Jason; Hu, Chao et al. (2016) Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles. Cancer Res 76:4470-80
Weng, Hengyou; Lal, Kumar; Yang, Frank F et al. (2015) The pathological role and prognostic impact of miR-181 in acute myeloid leukemia. Cancer Genet 208:225-9
Li, Zejuan; Chen, Ping; Su, Rui et al. (2015) Overexpression and knockout of miR-126 both promote leukemogenesis. Blood 126:2005-15
He, Y; Jiang, X; Chen, J (2014) The role of miR-150 in normal and malignant hematopoiesis. Oncogene 33:3887-93
Price, Colles; Chen, Jianjun (2014) MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives. Genes Dis 1:53-63
Li, Zejuan; Zhang, Zhiyu; Li, Yuanyuan et al. (2013) PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood 121:1422-31
Li, Zejuan; Herold, Tobias; He, Chunjiang et al. (2013) Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. J Clin Oncol 31:1172-81
Huang, Hao; Jiang, Xi; Li, Zejuan et al. (2013) TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A 110:11994-9

Showing the most recent 10 out of 24 publications